Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,610.00    -80.00 (-1.41%)
Bid:
5,620.00
Ask:
5,630.00
Spread: 10.00 (0.178%)
Market Cap: £3.00b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Director Appointments

23 Jun 2022 07:00

RNS Number : 8624P
Cranswick PLC
23 June 2022
 

23 June 2022

Cranswick plc(the "Company" or "the Group")

Director Appointments

Cranswick plc, a leading UK food producer, announces the appointment of Yetunde Hofmann as an independent Non-Executive Director of the Company and of Christopher Aldersley as an Executive Director of the Company, both with effect from 1 August 2022.

Yetunde Hofmann

Yetunde is the Managing Director of Synchrony Development Consulting, an international leadership and change consultancy that partners with leaders to facilitate strategy, change, diversity and inclusion and the founder of Solaris Global Executive Leadership Development. She is also a Trustee at the Institute of Business Ethics (IBE) and is a visiting fellow at the University of Reading's Henley Business School of Marketing and Reputation.

On appointment, Yetunde will become a member of the Audit, Remuneration, Nomination and ESG committees.

Yetunde is an independent Non-Executive Director at Treatt plc. No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Yetunde Hofmann's appointment as a Non-Executive Director of the Company.

Christopher Aldersley

Chris joined Cranswick in 1998 and since then has undertaken a variety of senior management roles, becoming the Group's Chief Operating Officer in 2015. Chris has responsibility for managing the operations at the Group's four primary processing and sixteen added value facilities and also for its agricultural operations, which support the Group's vertically integrated supply chain strategy.

The appointment of Chris to the Board recognises his contribution to the Group and central importance of his role going forward as a member of the Board to the delivery of the Group's long-term strategy.

On appointment, Chris will become a member of the ESG committee.

No other information is required to be disclosed pursuant to Listing Rule 9.6.13R in relation to Chris Aldersley's appointment as an Executive Director of the Company.

Tim Smith, Chairman of Cranswick plc, commented:

"I am delighted that Yetunde and Chris will join our Board.

"Yetunde's experience will complement our existing Board. She has an established track record of mentoring and developing performance, talent and leadership strategies across a range of organisations, which will be invaluable to Cranswick.

"Chris's role at Cranswick has grown with the rapid development of the Group and he has been central to facing the challenges presented in recent times by Brexit and the COVID-19 pandemic. Chris helps deliver our Second Nature sustainability strategy. I am pleased his contribution is recognised with his appointment to the Board.".

Enquiries:

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Powerscourt

020 7250 1446

Nick Dibden / Nick Hayns/Chloe Retief

cranswick@powerscourt-group.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFEERTIFFIF
Date   Source Headline
5th Sep 201711:50 amRNSDirector/PDMR Shareholding
5th Sep 201711:48 amRNSDirector/PDMR Shareholding
4th Sep 20172:51 pmRNSHolding(s) in Company
30th Aug 20178:39 amRNSAdditional Listing
18th Aug 20177:00 amRNSChange of Auditor
17th Aug 20179:32 amRNSHolding(s) in Company
31st Jul 20174:38 pmRNSCompany Secretary Change
31st Jul 20173:59 pmRNSTotal Voting Rights
27th Jul 20178:51 amRNSResult of AGM
24th Jul 20177:00 amRNSFirst Quarter Trading Statement
17th Jul 20179:24 amRNSHolding(s) in Company
12th Jul 20172:22 pmRNSDividend Declaration
10th Jul 20173:14 pmRNSDirector/PDMR Shareholding
30th Jun 20178:42 amRNSDirector/PDMR Shareholding
28th Jun 20179:23 amRNSDirector/PDMR Shareholding
19th Jun 20172:12 pmRNSHolding(s) in Company
30th May 20171:47 pmRNSHolding(s) in Company
26th May 20173:12 pmRNSHolding(s) in Company
23rd May 20171:40 pmRNSHolding(s) in Company
23rd May 20177:00 amRNSPreliminary Results
19th Apr 20178:57 amRNSHolding(s) in Company
5th Apr 201711:21 amRNSBlock listing Interim Review
5th Apr 201711:18 amRNSBlock listing Interim Review
3rd Apr 20171:39 pmRNSTotal Voting Rights
30th Mar 201710:48 amRNSDirector/PDMR Shareholding
30th Mar 201710:46 amRNSDirector/PDMR Shareholding
6th Mar 201710:50 amRNSDirector/PDMR Shareholding
6th Mar 201710:49 amRNSDirector/PDMR Shareholding
16th Feb 20175:32 pmRNSDirector/PDMR Shareholding
13th Feb 201710:28 amRNSBlock listing Interim Review
2nd Feb 20177:00 amRNSTrading Statement
27th Jan 20174:47 pmRNSDirector/PDMR Shareholding
27th Jan 20174:37 pmRNSDirector/PDMR Shareholding
27th Jan 20174:36 pmRNSDirector/PDMR Shareholding
24th Jan 20172:31 pmRNSAdditional Listing
19th Dec 20169:45 amRNSDividend Declaration
29th Nov 20167:00 amRNSHalf-year Report
16th Nov 20167:00 amRNSAcquisition of pork processing business
26th Oct 20163:46 pmRNSHolding(s) in Company
5th Oct 20161:41 pmRNSBlock listing Interim Review
5th Oct 20161:40 pmRNSBlock listing Interim Review
4th Oct 201610:38 amRNSTotal Voting Rights
22nd Sep 20162:34 pmRNSDirector/PDMR Shareholding
22nd Sep 20162:33 pmRNSDirector/PDMR Shareholding
14th Sep 20164:10 pmRNSDirector/PDMR Shareholding
14th Sep 20164:09 pmRNSDirector/PDMR Shareholding
14th Sep 20164:08 pmRNSDirector/PDMR Shareholding
23rd Aug 20161:28 pmRNSAdditional Listing
26th Jul 20169:42 amRNSResult of AGM
25th Jul 20167:00 amRNSTrading statement & sale of sandwich business

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.